Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United StatesJennifer L. Harcourt, Natalie J. Thornburg|Emerging infectious diseases|2020Cited by 628
The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trialNadine Rouphael, Wendy Nesheim, Regina Mosley et al.|The Lancet|2017Cited by 423
Isolation and characterization of SARS-CoV-2 from the first US COVID-19 patientJennifer L. Harcourt, Natalie J. Thornburg|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 155